Eli Lilly to inject $1 billion in contract manufacturing operations in India
American pharmaceutical giant Eli Lilly and Company is investing over $1 billion (approx Rs 8,900 crore) in India to establish new contract manufacturing facilities, including a significant hub in Hyderabad. This strategic move aims to bolster its global manufacturing and supply capabilities, leveraging India's skilled workforce to develop and produce medicines for critical ailments.
American pharmaceutical giant Eli Lilly and Company is investing over $1 billion (approx Rs 8,900 crore) in India to establish new contract manufacturing facilities, including a significant hub in Hyderabad. This strategic move aims to bolster its global manufacturing and supply capabilities, leveraging India's skilled workforce to develop and produce medicines for critical ailments.
